These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease. Martínez-Domínguez SJ; García-Mateo S; Gargallo-Puyuelo CJ; Gallego Llera B; Refaie E; Callau P; Mendi C; Baptista PM; Hernández Ainsa M; Arroyo-Villarino MT; López de la Cruz J; Martínez-García J; Alfambra E; Simón Marco MÁ; Ampuero J; Gomollón F Eur J Intern Med; 2024 Feb; 120():99-106. PubMed ID: 37872034 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare. Ritaccio G; Stoleru G; Abutaleb A; Cross RK; Shetty K; Sakiani S; Wong U Dig Dis Sci; 2021 Sep; 66(9):3186-3191. PubMed ID: 32894439 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Zamani M; Alizadeh-Tabari S; Singh S; Loomba R Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325 [TBL] [Abstract][Full Text] [Related]
9. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis. Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782 [TBL] [Abstract][Full Text] [Related]
10. Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease. Hyun HK; Lee HW; Park J; Park SJ; Park JJ; Kim TI; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU; Cheon JH Gut Liver; 2024 Mar; 18(2):294-304. PubMed ID: 37203442 [TBL] [Abstract][Full Text] [Related]
11. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500 [TBL] [Abstract][Full Text] [Related]
12. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease. Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445 [TBL] [Abstract][Full Text] [Related]
13. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography. Saroli Palumbo C; Restellini S; Chao CY; Aruljothy A; Lemieux C; Wild G; Afif W; Lakatos PL; Bitton A; Cocciolillo S; Ghali P; Bessissow T; Sebastiani G Inflamm Bowel Dis; 2019 Jan; 25(1):124-133. PubMed ID: 29889226 [TBL] [Abstract][Full Text] [Related]
14. NAFLD Is Associated With Quiescent Rather Than Active Crohn's Disease. McHenry S; Glover M; Ahmed A; Alayo Q; Zulfiqar M; Ludwig DR; Ciorba MA; Davidson NO; Deepak P Inflamm Bowel Dis; 2024 May; 30(5):757-767. PubMed ID: 37454277 [TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease. Navarro P; Gutiérrez-Ramírez L; Tejera-Muñoz A; Arias Á; Lucendo AJ Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960160 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. Yen HH; Su PY; Huang SP; Wu L; Hsu TC; Zeng YH; Chen YY PLoS One; 2021; 16(5):e0252286. PubMed ID: 34043691 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111 [TBL] [Abstract][Full Text] [Related]
18. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review. Kodali A; Okoye C; Klein D; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Moradi A; Hamid P Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212 [TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336 [TBL] [Abstract][Full Text] [Related]
20. Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature. McGowan CE; Jones P; Long MD; Barritt AS Inflamm Bowel Dis; 2012 Jan; 18(1):49-54. PubMed ID: 21351214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]